Literature DB >> 16930809

Atypical foci suspicious but not diagnostic of malignancy in prostate needle biopsies (also referred to as "atypical small acinar proliferation suspicious for but not diagnostic of malignancy").

Rodolfo Montironi1, Vincenzo Scattoni, Roberta Mazzucchelli, Antonio Lopez-Beltran, David G Bostwick, Francesco Montorsi.   

Abstract

OBJECTIVE: To review atypical focus suspicious but not diagnostic of malignancy in needle biopsies of the prostate, also referred to as "atypical small acinar proliferation suspicious for but not diagnostic of malignancy."
METHODS: A number of descriptive and somewhat confusing terms have been used to refer to a prostate tissue biopsy with small focus of atypical glands. Based on MEDLINE database searches, all aspects, including the synonymous terms, of atypical focus suspicious but not diagnostic of malignancy were examined.
RESULTS: An average of 5% of needle biopsy pathology reports show a diagnosis of atypical focus suspicious for malignancy. It may be composed of acini of small size, that is, smaller than normal ducts and acini, but may also include glands with a diameter similar to that of normal ducts and acini. It encompasses a variety of lesions, including benign mimickers of cancer and small foci of carcinoma that, for a variety of reasons, cannot be accurately diagnosed. Maximal diagnostic information should be gained on section stained with haematoxylin and eosin, with immunohistochemical stains used for confirmation. Its presence in a biopsy set is a strong predictor for concurrent or subsequent adenocarcinoma. The values range from 17% to 60%, the mean being 40.7%. The precise labelling of the initial biopsies is mandatory so that rebiopsy of patients with atypical foci can be directed in a more concentrated fashion into the region of the initial biopsy.
CONCLUSION: The presence of atypical focus suspicious but not diagnostic of malignancy in needle biopsies is an important predictor of cancer compared with biopsies from patients who lack this finding.

Entities:  

Mesh:

Year:  2006        PMID: 16930809     DOI: 10.1016/j.eururo.2006.07.048

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  20 in total

1.  [Importance of second opinions on histology of prostate biopsy specimens].

Authors:  B Helpap; U Oehler
Journal:  Pathologe       Date:  2012-03       Impact factor: 1.011

2.  Molecular mapping of tumor heterogeneity on clinical tissue specimens with multiplexed quantum dots.

Authors:  Jian Liu; Stephen K Lau; Vijay A Varma; Richard A Moffitt; Matthew Caldwell; Tao Liu; Andrew N Young; John A Petros; Adeboye O Osunkoya; Tracey Krogstad; Brian Leyland-Jones; May D Wang; Shuming Nie
Journal:  ACS Nano       Date:  2010-05-25       Impact factor: 15.881

3.  Incidence, grade and distribution of prostate cancer following transperineal template-guided mapping biopsy in patients with atypical small acinar proliferation.

Authors:  Gregory S Merrick; Robert W Galbreath; Abbey Bennett; Wayne M Butler; Edward Amamovich
Journal:  World J Urol       Date:  2016-11-29       Impact factor: 4.226

Review 4.  Atypical small acinar proliferation (ASAP): Is a repeat biopsy necessary ASAP? A multi-institutional review.

Authors:  A Leone; B Gershman; K Rotker; C Butler; J Fantasia; A Miller; A Afiadata; A Amin; A Zhou; Z Jiang; T Sebo; A Mega; S Schiff; G Pareek; D Golijanin; J Yates; R J Karnes; J Renzulli
Journal:  Prostate Cancer Prostatic Dis       Date:  2015-11-17       Impact factor: 5.554

5.  Atypical small acinar proliferation at index prostate biopsy: rethinking the re-biopsy paradigm.

Authors:  Leslie A Ynalvez; Christopher D Kosarek; Preston S Kerr; Ali M Mahmoud; Eduardo J Eyzaguirre; Eduardo Orihuela; Joseph N Sonstein; Stephen B Williams
Journal:  Int Urol Nephrol       Date:  2017-10-24       Impact factor: 2.370

6.  Pathologic results of radical prostatectomies in patients with simultaneous atypical small acinar proliferation and prostate cancer.

Authors:  Kwang Ho Kim; Yun Beom Kim; Jeong Kee Lee; Yoon Jung Kim; Tae Young Jung
Journal:  Korean J Urol       Date:  2010-06-21

7.  Audit of rapid access introduction reveals high prevalence of prostate cancer in Western Region.

Authors:  E M Bolton; B D Kelly; M R Quinlan; F T D'Arcy; M Azar; C M Dowling; M Power; P McCarthy; C Roche; K Walsh; E Rogers; G C Durkan
Journal:  Ir J Med Sci       Date:  2013-07-19       Impact factor: 1.568

8.  High-grade prostatic intraepithelial neoplasia and atypical small acinar proliferation on initial 21-core extended biopsy scheme: incidence and implications for patient care and surveillance.

Authors:  Guillaume Ploussard; Gwendoline Plennevaux; Yves Allory; Laurent Salomon; Sandy Azoulay; Dimitri Vordos; Andreas Hoznek; Claude-Clément Abbou; Alexandre de la Taille
Journal:  World J Urol       Date:  2009-04-17       Impact factor: 4.226

9.  Can a supervised algorithmic assessment of men for prostate cancer improve the quality of care? A retrospective evaluation of a prostate assessment pathway in Saskatchewan.

Authors:  Bonnie Liu; Kunal Jana; Gary Groot
Journal:  Can Urol Assoc J       Date:  2017-09       Impact factor: 1.862

10.  Development and validation of risk score for predicting positive repeat prostate biopsy in patients with a previous negative biopsy in a UK population.

Authors:  Mark A Rochester; Nora Pashayan; Fiona Matthews; Andrew Doble; John McLoughlin
Journal:  BMC Urol       Date:  2009-07-16       Impact factor: 2.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.